Jane Bu
U.S. Chief Licensing Officer, Via Licensing Alliance As the Chief Licensing Officer at Via Licensing Alliance, Jane Bu is a pivotal member of the executive team. Her deep expertise in intellectual property strategy and multi-party licensing programs is widely recognized within the industry, and she is a frequent speaker at international IP events. Leveraging more […]
Lew Zaretzki
Managing Director, Hamilton IPV Lew is a strategy consultant serving major high-tech industry firms and investors in matters involving IP (especially cellular, digital video, and other SEPs). Engagements include M&A engagements (both buy and sell-side), corporate strategy, departmental IP strategy, individual licensing programs & engagements, disputes, and analytical endeavors such as valuation. Lew and his co-authors […]
Alejandra Loaiza Delgado
Managing Director, EconEdge, LLC Alejandra Loaiza Delgado is a Co-Founder and Managing Director at EconEdge LLC. Ms. Loaiza-Delgado is an expert valuation consultant with extensive experience in intellectual property valuation and the determination of economic damages in litigation. Ms. Loaiza-Delgado began her consulting practice in 2016. Since then, she has consulted in over 90 engagements […]
Steven Geiszler
U.S. Chief Intellectual Property Counsel, Huawei Steven is U.S. Chief Intellectual Property Counsel for Huawei. Based in Dallas, he leads a team responsible for patent licensing, prosecution, litigation, and transactions. Steven practiced for 15 years at international law firms, handling patent litigation in venues such as the Eastern District of Texas, District of Delaware, and […]
Tim Pohlmann
CEO, LexisNexis IPlytics Tim is the founder of IPlytics and served as its CEO for ten years. After the acquisition of IPlytics by LexisNexis, he took on the role of Director of SEP Analytics at LexisNexis Intellectual Property Solutions. Tim founded IPlytics with the vision of revolutionizing how IP professionals approach patent and standards data. […]
Jason Ding
Chief Business Officer, Entos Pharmaceuticals Jason has over 20 years of financial and transactional expertise in the life science and healthcare industry and is currently the Chief Business Officer of Entos Pharmaceuticals. Prior to joining Entos, Mr. Ding served as a Partner and Senior Managing Director in Deloitte’s investment banking practice and as the National […]
James Zanewicz
Chief Strategy Officer, Tulane University School of Medicine In his role as Chief Strategy Officer, James Zanewicz, JD, LLM, RTTP serves as the principal biomedical business development strategist and connectivity officer to industry, venture capital and other external collaborators; as well as overseeing marketing & communications, working on change-oriented special projects, and crisis management for […]
Gayatri Varma
Executive Director, Head of Transactions, Oncology Business Development & Licensing, AstraZeneca As Head of Transactions, Business Development at AstraZeneca, Gayatri oversees transactional activity for Oncology R&D. During her time at AstraZeneca, Gayatri has led and negotiated many transactions including the acquisition of Neogene Therapeutics, Gracell Biotechnologies and in-licensing of several oncology pre-clinical, clinical-stage assets, and […]
Adam Falconi
Attorney, Mintz LLP Adam is a Chambers-ranked attorney with a burgeoning life sciences practice, where he advises industry clients and investors on a broad spectrum of corporate governance, transactional and finance matters. His clients include a wide range of life science and health care companies, as well as venture capital and private equity funds. Adam […]
Ralf Raud
Lead Engineer and Co-Founder, Instafloss
